Sponsor
Cellectis, S.A.
Status of enrollment
Accepting new patients
Ages Eligible for Study
Open to adults ages 18 to 64
Genders Eligible for Study
Females and Males
Disease indication
Multiple Myeloma
Principal Investigator
Alfred Chung, MD
Contact
Justin Zheng
Additional study eligibility details can be found at UCSF Clinical Trials.